Garvan News Drawing the correct conclusions from clusters of dataMEDIA RELEASE: 18 Aug 2010 There’s a science to analysing science, say Garvan researchers, and some common methods of analysis can lead to completely incorrect study conclusions, particularly if experiments rely on 'clustered data'. MoreCreating clarity around a key aspect of the immune systemMEDIA RELEASE: 16 Aug 2010 Garvan researchers have made a finding on the frontier of immunology that will create much buzz in the field as it explains how a pivotal class of immune cells, known as T follicular helper cells, is generated. MoreWhy a common HIV drug increases risk of heart attackMEDIA RELEASE: 28 Jul 2010 Clinical researchers at Garvan and St. Vincent's Hospital have for the first time shown why a commonly used type of HIV drug is associated with a higher risk of heart attack. MoreYoung Sydney professionals give researchers a flying start27 Jul 2010 Two young scientists from the Garvan Institute of Medical Research have received a significant boost to their research into breast cancer and Type 2 diabetes, thanks to support from Young Garvan, a group of Sydney professionals committed to progressing awareness of and funding for medical research. MoreNew drug a potential treatment for Type 2 diabetesMEDIA RELEASE: 22 Jul 2010 Garvan scientists, in association with US pharmaceutical company DiaKine Therapeutics, have shown that a drug candidate, Lisofylline, could be useful in treating Type 2 diabetes. Lysofylline, an anti-inflammatory drug, is currently undergoing clinical trials for other diseases. MoreShot in the arm for Type 1 diabetes prevention in AustraliaMEDIA RELEASE: 14 Jul 2010 The Federal Government has committed $6.5 million over the next five years for the Diabetes Vaccine Development Centre (DVDC), based at Garvan, to continue its work. DVDC is searching for ways to prevent the development of Type 1 diabetes, including vaccination and immunotherapy, and to preserve insulin-producing cells from the early stages of disease. MoreSimple diagnostic tool predicts Type 2 diabetes in South East AsiansMEDIA RELEASE: 07 Jul 2010 Researchers have estimated the prevalence of Type 2 diabetes in Vietnam, and have developed a simple tool for identifying individuals at high risk. In Ho Chi Minh City, a city of 6.4 million, the findings suggest that around 350,000 have diabetes, many of whom are unaware of the fact. MoreA powerful gut hormone that affects insulin and blood sugar levelsMEDIA RELEASE: 16 Jun 2010 Garvan researchers, in collaboration with English colleagues, have shown that a gut hormone released after we eat determines the speed at which we digest food and absorb nutrients across the gut into our blood. This makes it very influential in disorders such as Type 2 diabetes, and a promising therapeutic target. More |
Events St Vincents and Mater Health Sydney Research Symposium24 Sep 2010
Scientific
5th Garvan Signalling Symposium18 Oct 2010
Scientific
International search for new Garvan Executive Director Following the decision of current Executive Director Professor John Shine to retire as of July 2011, the Garvan Board has instigated an international search for a suitable replacement. Click here to download brochure. St Vincents and Mater Health Sydney Research Symposium 24 September 2010 This annual Symposium draws upon research from institutions across the St Vincent's Campus. 5th Garvan Signalling Symposium 18-19 October 2010 International and national speakers will discuss the latest advancements in cell signalling research. Click here for further details and to register. ANZOS - Garvan 2010 Symposium 20 October 2010 "New Advances in Gut Function in Obesity". Please register by
Friday 17 September. Translational Genomics Symposium30 November 2010 Using next generation sequencing to pick the right drug for the right patient. Garvan Links TOUR GARVAN
FRACTURE RISK CALCULATORBased on data from the 18-year Dubbo Osteoporosis Epidemiology Study. For men and women 60 years and over to assess their individual risk of fracture. www.fractureriskcalculator.com
AUSTRALIAN PANCREATIC CANCER GENOME INITIATIVEGarvan is involved in the Australian arm of the The International Cancer Genome Consortium – by investigating pancreatic cancer. For more information click here. |
